Prevalence and dissemination of the Ser315Thr substitution within the KatG enzyme in isoniazid-resistant strains of Mycobacterium tuberculosis isolated in Uruguay | Zendy

Gustavo Varela | Zendy; Sabina González | Zendy; Pilar Gadea | Zendy; Cecilia Coitinho | Zendy; Inés Mota | Zendy; Gladys González | Zendy; Fernando Goñi | Zendy; Carlos Rivas | Zendy; Felipé Schelotto | Zendy

Open Access

Prevalence and dissemination of the Ser315Thr substitution within the KatG enzyme in isoniazid-resistant strains of Mycobacterium tuberculosis isolated in Uruguay

Author(s) -

Gustavo Varela,

Sabina González,

Pilar Gadea,

Cecilia Coitinho,

Inés Mota,

Gladys González,

Fernando Goñi,

Carlos Rivas,

Felipé Schelotto

Publication year - 2008

Publication title -

journal of medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.91

H-Index - 117

eISSN - 1473-5644

pISSN - 0022-2615

DOI - 10.1099/jmm.0.2008/001917-0

Subject(s) - isoniazid , mycobacterium tuberculosis , tuberculosis , strain (injury) , microbiology and biotechnology , biology , virology , mycobacterium , polymerase chain reaction , gene , bacteria , medicine , genetics , pathology , anatomy

The aim of this study was to determine the prevalence of Ser315Thr substitution in isoniazid (INH)-resistant strains of Mycobacterium tuberculosis in Uruguay. The katG gene of 62 INH-resistant strains was analysed by an RFLP-PCR assay. PCR products were digested with MspI to detect Ser315Thr and Arg463Leu substitutions. A total of 16 of the 62 (26 %) INH-resistant strains analysed had a Ser315Thr substitution. Only one INH-resistant strain had an Arg463Leu substitution and two strains had a deletion in katG. Of the 16 strains with Ser315Thr, 15 showed different profiles using a double-repetitive-element PCR assay, demonstrating that there was no local dissemination of any particular strain. These findings are in agreement with published data from regions where the prevalence of tuberculosis (TB) is intermediate and may be due in part to the success of the local TB control programme.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research